Inside Angle

From 3M Health Information Systems

Tag: FDA

Blog Post

AI Talk: Predicting breast cancer, regulating SaMD, predicting mutations

February 5, 2021 / By V. “Juggy” Jagannathan, PhD

Predicting Breast Cancer This week, MIT News featured a good discussion of some fresh new research published in Science Translational Medicine. Adam Yala, an MIT researcher, led this multi-year, multi-site […]

Blog Post

A refresher on the coding of poisoning, underdosing, toxic and adverse effects during the pandemic

June 10, 2020 / By Sue Belley, RHIA

Update: On June 15, several days after this blog posted, the FDA revoked their Emergency Use Authorization for hydroxychloroquine and chloroquine for the treatment of COVID-19. The alert states, “Based […]

Blog Post

Striking the Right Balance with Oversight of Health IT

September 16, 2013 / By Camille Cohen

Strides seem to have been made towards a moderate approach to the oversight of Health IT. When I read recently that the Health Information Technology Policy Committee (HITPC) of the […]